We are live on ! Find out more
IVOP

iPath Inverse S&P 500 VIX Short-Term Futures
IVOP

Delisted

IVOP was delisted on the 23rd of March, 2018.

Back to rankings

2 hedge funds and large institutions have $442K invested in iPath Inverse S&P 500 VIX Short-Term Futures in 2017 Q1 according to their latest regulatory filings, with funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

6% less capital invested

Capital invested by funds: $471K → $442K (-$29K)

33% less funds holding

Funds holding: 3 → 2 (-1)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 1

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 1

Holders
2
Holders Change
-1
Holders Change %
-33.33%
% of All Funds
0.05%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
1
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
UBS Group
UBS Group
Switzerland
-$33K
2
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$115
Name Holding Trade Value Shares
Change 		Change in
Stake
Susquehanna International Group
1
Susquehanna International Group
Pennsylvania
$442K -$115 -3 -0%
UBS Group
2
UBS Group
Switzerland
– -$33K -860 Closed

IVOP Hedge Fund Activity: Q1 2017 in Review

2 of the 4,018 institutional investors tracked by Wall St. Rank reported a position in iPath Inverse S&P 500 VIX Short-Term Futures (IVOP) for Q1 2017, worth a combined $442K — down 6.2% from $471K a quarter earlier.

Sellers outnumbered buyers: 1 fund closed out of IVOP and 0 opened new positions — a net loss of 1 holder — while 1 trimmed existing stakes and 0 added.

The largest seller was UBS Group, exiting entirely with an estimated $33K sold.

  • 2 institutional investors held iPath Inverse S&P 500 VIX Short-Term Futures (IVOP) as of Q1 2017, down from 3 in Q4 2016.
  • Funds reported $442K of iPath Inverse S&P 500 VIX Short-Term Futures stock for Q1 2017, down 6.2% quarter-over-quarter.
  • 0 funds opened new iPath Inverse S&P 500 VIX Short-Term Futures positions in Q1 2017 and 1 closed out, a net change of -1 holder.
  • The largest iPath Inverse S&P 500 VIX Short-Term Futures seller in Q1 2017 was UBS Group, an estimated $33K sold.

Based on aggregated 13F filings for Q1 2017.